NSRX

Nasus Pharma Ltd$4.10 1.23%
Health CareUSCUSIP M7071P109· EOD Aug 27, 2026◍ Confluence graph
Tracked 13F Holders
7
+4 QoQ
13F Value (tracked)
$5.7M
Insider Net · 180d
$62K
1↑ 0↓
Recent Filings
4
Smart-money sentimentBullish
BearishBullish
13F funds (latest Q)4 adding · 0 trimming
Insider net (180d)+$62K

Price & smart-money activity

$4.10 1.23%1Y -50.3%
$1.44$3.51$5.58$7.65$9.72Aug 2025OctJan 2026MarJunAug4
Hover for who · click for detailEnd-of-day closing prices52w $2.01 – $9.15

Who owns NSRX?

7 tracked 13F filers

7 tracked 13F filers disclose a position in NSRX as of the latest SEC 13F filings, a combined $5.7M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundPosition valueSharesLast moveAs ofHistory
1BALYASNY ASSET MANAGEMENT L.P.
$2.0M
898K
New
+898K sh
Q1 2026
2Cable Car Capital, LP
$2.2M
616K
+2.3%
Added · +14K sh
Q2 2026
3Velan Capital Investment Management LP
$1.3M
359K
Held
Q2 2026
4Hudson Bay Capital Management LP
$299K
135K
New
+135K sh
Q1 2026
5UBS Group AG
$7K
3K
+719%
Added · +3K sh
Q1 2026
6MORGAN STANLEY
$4K
2K
Held
Q1 2026
7Caitong International Asset Management Co., Ltd
$14
4
New
+4 sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is NSRX being bought or sold by institutions?

Last quarter, 3 funds opened a new position in NSRX and 1 added to an existing one, while 0 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened (NEW)
3
funds
Added
1
funds
Reduced
0
funds
Exited
0
funds

Funds that own NSRX also own

CompanyCo-held byCombined value
NVIDIA CORPNVDA4 funds$2.0B
AMAZON.COM INCAMZN4 funds$1.6B
TESLA INCTSLA4 funds$1.1B
MICRON TECHNOLOGY INCMU4 funds$565.9M
TAIWAN SEMICONDUCTOR-SP ADRTSM4 funds$442.8M
ALPHABET INC-CL CGOOG4 funds$205.0M
XPO INCXPO4 funds$116.0M
FORGENT POWER SOLUTIONS INCFPS4 funds$85.9M
EUPRAXIA PHARMACEUTICALS INCEPRX4 funds$12.8M
FORTE BIOSCIENCES INCFBRX4 funds$9.5M
CYTOMX THERAPEUTICS INCCTMX4 funds$4.3M
REPLIMUNE GROUP INCREPL4 funds$1.6M

Ranked by how many of NSRX's institutional holders also hold each name, a cross-fund conviction signal.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$62K
1 insiders
Sells · 180d
$0
0 insiders
Net
$62K
3 P/S txns
Signal
Net Buying
open-market
DateInsiderRoleActionSharesValue
Jun 17, 2026Teleman Dan BenjaminChief Executive Officer, DirectorBuy (P)7K$20K
Apr 22, 2026Teleman Dan BenjaminChief Executive Officer, DirectorBuy (P)3K$11K
Mar 31, 2026Teleman Dan BenjaminChief Executive Officer, DirectorBuy (P)15K$31K

Institutional ownership over time

6 funds+4 since Q3 2025
036Q3 2025Q4 2025Q1 2026
funds holding aggregate valuelatest $4.4M

Recent filings

4 shown

Keep exploring

Connected entities for NSRX

Browse more

Build

Ask your agent what changed in NSRX

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/NSRX/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for NSRX.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NSRX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.